Kendle's Charles River Labs buyout clouds Q2
A charge due to the acquisition of a Charles River Laboratories' unit a year ago has put a cloud on Kendle's Q2 otherwise all-time high performance.
Archives for August 1, 2007
HIV therapy leads way in personalised medicine
GlaxoSmithKline (GSK) has opened the flood gates into the world of personalised medicine with the world's first ever approved genetic test, which predicts a life threatening side effect of one of its antiretroviral drugs.
Illuminating the future of drug delivery
Irish researchers have developed a technique that could be used to deliver controlled amounts of drugs to diseased tissues while minimising side effects simply by shining light on the target.
CSL Behring invests $15m in Kankakee expansion
CSL Behring is investing in a new $15m expansion of its Kankakee plant in Illinois.
Genentech completes its first-ever acquisition
US biotech giant Genentech has announced it has completed its first-ever acquisition, buying Tanox for $919m (€672m).
Pharmaceutical contract services round-up
In a round-up of motley pharmaceutical services news, Outsourcing-Pharma takes a look at recent announcements involving Quintiles, Kenexa, Atos, Catalent Pharma, Patni and Taratec.
Statin-based drug touted as Tamiflu rival
A statin-based drug candidate is being touted as a potential rival to Roche's flu vaccine Tamiflu (oseltamivir phosphate) after its developers revealed yesterday that it showed "superiority" in the preclinic.
Merck bulks up cardiovascular pipeline
Merck & Co. is to bolster its late-stage cardiovascular pipeline through the acquisition of US-based pharma company NovaCardia.
MDS Pharma expands services in EU market
MDS Pharma Services has announced it is expanding its development and regulatory services (DRS) business in Europe while its bioanalytical operations are still struggling.
First ever non-contact process protects film-coated tabs
Solid-dose specialist Colorcon has hooked up with materials science firm DataLase to develop a new no-touch on-tablet marking technique specifically for film-coated tablets, helping to defend branded tabs from counterfeiting attempts and protect...
Outsourcing-Pharma.com special focus
Latest twists and turns in Inyx saga
The latest twists and turns in the Inyx Inc. bankruptcy saga include an attempted power seize by its creditor, fraud allegations thrown around courtrooms and in the media, the resignation of Inyx' accountants, and increasing signs of links between...
Company Profile: Thermo Fisher Scientific
LabTechnologist.com brings you an exclusive interview with Greg Herrema - president of the Scientific Instruments division of Thermo Fisher Scientific.